These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30578453)

  • 1. Is it possible to determine the level of functional impairment that distinguishes the patients with ADHD from those without ADHD?
    Tarakçıoğlu MC; Gökler ME; Kadak MT; Çakın Memik N; Aksoy UM
    Qual Life Res; 2019 Apr; 28(4):1097-1103. PubMed ID: 30578453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Weiss Functional Impairment Rating Scale-Parent Form for assessing ADHD: evaluating diagnostic accuracy and determining optimal thresholds using ROC analysis.
    Thompson T; Lloyd A; Joseph A; Weiss M
    Qual Life Res; 2017 Jul; 26(7):1879-1885. PubMed ID: 28220338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receiver operating characteristic curve analysis of the Weiss Functional Impairment Rating Scale-Parent Report for screening children with ADHD: Looking beyond symptoms in ADHD diagnosis.
    Kiani B; Hadianfard H; Weiss MD; Dehbozorgi S
    Early Interv Psychiatry; 2024 Jun; 18(6):431-438. PubMed ID: 38030566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional impairment outcomes in clinical trials of different ADHD medications: post hoc responder analyses and baseline subgroup analyses.
    Coghill DR; Werner-Kiechle T; Farahbakhshian S; Bliss C; Robertson B; Huss M
    Eur Child Adolesc Psychiatry; 2021 May; 30(5):809-821. PubMed ID: 32691164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychometric properties of the Japanese version of the Weiss Functional Impairment Rating Scale: Self-Report.
    Takeda T; Tsuji Y; Kanazawa J; Sakai T; Weiss MD
    Atten Defic Hyperact Disord; 2017 Sep; 9(3):169-177. PubMed ID: 28013402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does Guanfacine Extended Release Impact Functional Impairment in Children with Attention-Deficit/Hyperactivity Disorder? Results from a Randomized Controlled Trial.
    Stein MA; Sikirica V; Weiss MD; Robertson B; Lyne A; Newcorn JH
    CNS Drugs; 2015 Nov; 29(11):953-62. PubMed ID: 26547425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychometric properties of the Weiss Functional Impairment Rating Scale parent and self-reports in a Norwegian clinical sample of adolescents treated for ADHD.
    Haugan AJ; Sund AM; Thomsen PH; Lydersen S; Nøvik TS
    Nord J Psychiatry; 2021 Jan; 75(1):63-72. PubMed ID: 32749193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric validation of the Weiss Functional Impairment Rating Scale-Parent Report Form in children and adolescents with attention-deficit/hyperactivity disorder.
    Gajria K; Kosinski M; Sikirica V; Huss M; Livote E; Reilly K; Dittmann RW; Erder MH
    Health Qual Life Outcomes; 2015 Nov; 13():184. PubMed ID: 26577642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidate.
    Nagy P; Häge A; Coghill DR; Caballero B; Adeyi B; Anderson CS; Sikirica V; Cardo E
    Eur Child Adolesc Psychiatry; 2016 Feb; 25(2):141-9. PubMed ID: 25999292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric properties of a modified version of the Weiss Functional Impairment Rating Scale-Parent Report (WFIRS-P) in a clinical sample of children with aggressive behavior.
    Kernder T; Doepfner M; Dose C; Goertz-Dorten A
    Qual Life Res; 2019 Jan; 28(1):241-251. PubMed ID: 30276506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating minimal important differences for several scales assessing function and quality of life in patients with attention-deficit/hyperactivity disorder.
    Hodgkins P; Lloyd A; Erder MH; Setyawan J; Weiss MD; Sasané R; Nafees B
    CNS Spectr; 2017 Feb; 22(1):31-40. PubMed ID: 27535815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of DSM-5 age-of-onset criterion of attention deficit/hyperactivity disorder (ADHD) in adults: Comparison of life quality, functional impairment, and family function.
    Lin YJ; Lo KW; Yang LK; Gau SS
    Res Dev Disabil; 2015 Dec; 47():48-60. PubMed ID: 26318976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Descriptive and psychometric properties of the Persian version of the Weiss functional impairment rating scale: parent report form in Iranian children.
    Kiani B; Hadianfard H; Weiss MD
    Health Qual Life Outcomes; 2018 Dec; 16(1):225. PubMed ID: 30526625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of an Ecological Executive Skill Training Program for School-aged Children with Attention Deficit Hyperactivity Disorder: A Randomized Controlled Clinical Trial.
    Qian Y; Chen M; Shuai L; Cao QJ; Yang L; Wang YF
    Chin Med J (Engl); 2017 Jul; 130(13):1513-1520. PubMed ID: 28639564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the Weiss Functional Impairment Rating Scale (WFIRS-P) as a Functional Impairment Measure in a General Population of Schoolchildren.
    Arildskov TW; Virring A; Thomsen PH; Lambek R
    Assessment; 2023 Dec; 30(8):2533-2544. PubMed ID: 36799215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Randomized, Placebo-Controlled Trial of Guanfacine Extended Release in Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Wilens TE; Robertson B; Sikirica V; Harper L; Young JL; Bloomfield R; Lyne A; Rynkowski G; Cutler AJ
    J Am Acad Child Adolesc Psychiatry; 2015 Nov; 54(11):916-25.e2. PubMed ID: 26506582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posttraumatic stress disorder in adult attention-deficit/hyperactivity disorder: clinical features and familial transmission.
    Antshel KM; Kaul P; Biederman J; Spencer TJ; Hier BO; Hendricks K; Faraone SV
    J Clin Psychiatry; 2013 Mar; 74(3):e197-204. PubMed ID: 23561240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spanish validation of the adult Attention Deficit/Hyperactivity Disorder Rating Scale (ADHD-RS): relevance of clinical subtypes.
    Richarte V; Corrales M; Pozuelo M; Serra-Pla J; Ibáñez P; Calvo E; Corominas M; Bosch R; Casas M; Ramos-Quiroga JA
    Rev Psiquiatr Salud Ment; 2017; 10(4):185-191. PubMed ID: 28844652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The usefulness of Conners' Rating Scales-Revised in screening for attention deficit hyperactivity disorder in children with intellectual disabilities and borderline intelligence.
    Deb S; Dhaliwal AJ; Roy M
    J Intellect Disabil Res; 2008 Nov; 52(11):950-65. PubMed ID: 18179511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.